-
Viral immunotherapy confers ‘striking’ survival benefit in advanced lung cancer
05 May 2025 23:34 GMT
… M. Heisler Professor for Lung Cancer Excellence at University of … patients will eventually experience recurrence. We urgently need new … solid tumors, including lung cancer, prostate cancer and … bronchoscopic injection into the lung tumor, positive lymph node …
-
AstraZeneca opens the door to Imfinzi expansion with trial win in high-risk bladder cancer patients
09 May 2025 19:51 GMT
… randomization to the first recurrence of high-risk … for disease progression or recurrence.
The new Imfinzi trial … to surgery, disease progression, recurrence or death, compared with … small cell lung cancer, limited-stage small cell lung cancer, biliary tract …
-
Imfinzi Regimen Demonstrates Positive, Meaningful Outcomes in Phase III Bladder Cancer Trial
09 May 2025 17:46 GMT
… without high-risk disease recurrence or progression. While most … limited-stage small cell lung cancer disease has not progressed … limited-stage small cell lung cancer in Europe, bringing them … for limited-stage small cell lung cancer. News release. AstraZeneca. …
-
Comorbidities in midlife have distinct associations with cancer development
09 May 2025 17:34 GMT
… a 30% higher risk for recurrence if they had experienced a … -1.79); respiratory conditions with lung cancer (HR = 1.8; 95% CI … also had lower risk for lung cancer (HR = 0.75; 95% CI …
-
IMFINZI® (durvalumab) regimen demonstrated statistically significant and clinically meaningful improvement in disease-free survival for high-risk non-muscle-invasive bladder cancer in POTOMAC Phase III trial
09 May 2025 11:20 GMT
… for disease progression or recurrence because of certain … Limited-stage Small Cell Lung Cancer
In patients with limited … Extensive-stage Small Cell Lung Cancer
In patients with extensive- … extensive-stage small cell lung cancer (ES-SCLC).
IMFINZI, …
-
Decoding ARF4 and EIF5B-Based Prognostic Signatures and Immune Landscape Following Insufficient Radiofrequency Ablation in Hepatocellular Carcinoma: Through Multi-Omics and Experimental Validation
09 May 2025 10:21 GMT
… -related targets influencing tumor recurrence. Presently, numerous biomarkers, … may predict the recurrence of hepatocellular carcinoma … of PD-L1 in lung cancer. Nat Cancer. 2020 … induces antitumor responses against recurrence of hepatocellular carcinoma. …
-
Cancer Patients’ Behavior and Perception on the Use of Medical Foods and Dietary Supplements During Chemotherapy
09 May 2025 10:21 GMT
… were important for preventing cancer recurrence. These misconceptions highlight the importance … intakes in non-small cell lung cancer patients receiving chemotherapy. Thai JPEN …
-
AstraZeneca’s Imfinzi delays bladder cancer return in high-risk...
09 May 2025 06:57 GMT
… live without high-risk disease recurrence or progression,” she said.
Non … , including muscle-invasive bladder cancer, lung cancer, and certain liver and biliary …
-
Accelerated FDA Approval Makes Verastem Drug the First Therapy for Rare Type of Ovarian Cancer
09 May 2025 01:59 GMT
… well to those treatments and recurrence is common.
Discover what tools … for treating non-small cell lung cancer driven by KRAS G12C mutations … combination in non-small cell lung cancer and pancreatic cancer.
As of …
-
Concurrent Chemoradiation May Improve LS-SCLC Prognosis
08 May 2025 18:11 GMT
… limited-stage small cell lung cancer (LS-SCLC), with … patients with other sites of recurrence.
Based on multivariate analysis … in limited-stage small cell lung cancer: implications for clinical practice … limited‑stage small cell lung cancer. Oncol Lett. 2024; …
About
© 1995-2025